Jubilant Ingrevia reports robust growth in Q2 FY26

Jubilant Ingrevia Limited reported a significant financial uplift for Q2 FY26, with total revenue reaching INR 1,121 crore, an 8% increase quarter-on-quarter and 7% year-on-year. Profit After Tax surged by 18% year-on-year to INR 70 crore, contributing to a 34% increase in PAT for the half-year to INR 145 crore. Basic and Diluted EPS also grew by 18% year-on-year to INR 4.4. The Specialty Chemicals segment was a key driver, achieving 25%+ margins and contributing 75% to EBITDA.

The company's EBITDA for Q2 FY26 stood at INR 146 crore, an 8% increase year-on-year. This growth was bolstered by strong performances in Fine Chemicals and CDMO sales within the Specialty Chemicals segment, and sustained volume growth in the Nutrition business. Chemical Intermediates also recorded its highest quarterly sales in value and volumes in the last six quarters.

Jubilant Ingrevia is progressing with strategic initiatives, including the Q4 commissioning of a $300m Agro-Innovator project and the groundbreaking of a new Multipurpose Plant (MPP) in Gajraula. The company also reported over 100 active leads in its Key Account Management funnel and secured more than 10 new molecules in the past year, with an estimated peak annual revenue potential of INR 1,200 crore.